Back to ALL
ALL Stock: Earnings Beat, Risks and Valuation
$ALLNEUTRALInsurance—Property & Casualty

ALL Stock: Earnings Beat, Risks and Valuation

Allstate’s reported November earnings beat and low stated P/E are offset by mixed analyst views and price targets near the November 13 close. This report reviews the company’s financial signals, insurance risks, valuation caveats and potential catalysts.

November 14, 202610 min read
Current Price
$267.64
+0.36%
Analyst Rating
Buy
Price Target
$266.47
-0.4% upside
P/E Ratio
5.98

Executive Summary

Investment Thesis: Allstate’s reported third-quarter adjusted EPS of $9.76 exceeded the $6.89 estimate, while its stated trailing P/E of 5.98 suggests the shares are priced modestly against recent earnings. That apparent value needs context: insurance earnings can swing with catastrophe losses, pricing and investment results, and supplemental financial data supplied here show sharply negative earnings growth. The analyst target mean of $266.47 is close to the November 13 close, leaving no consensus indication of substantial near-term appreciation.

Current Price: $267.64 as of Friday, November 13 | Key Metric: Q3 EPS of $9.76 vs. $6.89 estimate | Stance: NEUTRAL

U.S. stock markets are closed Saturday, November 14. The price and daily change in this report refer to Friday’s session, and the next regular session is Monday, November 16. Figures from separate data feeds conflict in several places, so valuation and financial metrics should be treated as source-dependent rather than perfectly reconciled.

Company Overview

The Allstate Corporation is a U.S. insurer focused on property and casualty coverage, particularly personal auto and homeowners insurance. It sells through Allstate agents, independent agents, direct channels and affiliated brands, and also operates businesses such as protection products and roadside services.

Key Products & Competitive Position

  • Core Business: Personal lines insurance, including auto and homeowners policies, alongside selected commercial and specialty coverage.
  • Key Products: Auto, home, renters, condominium, life and identity-protection products, plus roadside assistance and other services.
  • Competitive Moat: A nationally recognized brand, large distribution network, customer and claims data, and the ability to spread operating costs across a substantial policy base. These advantages support competition but do not eliminate underwriting or catastrophe risk.

Recent Developments

CEO Tom Wilson discussed insurance affordability, autonomous vehicles, artificial intelligence and the economy in a CNBC interview on November 10. These themes matter to Allstate’s longer-term cost structure and risk selection, though the interview summary provided no quantified financial targets. The company also announced a $1.08 quarterly dividend payable January 4, 2027, and published a Thanksgiving driving-safety report using Drivewise data.

Financial Snapshot

Market Cap$66.23B
P/E Ratio5.98
52-Week Range$191.13 - $281.11
Dividend Yield1.58%
EPS (TTM)$46.28
ROE36.32%

Revenue & Earnings Trends

The most recent reported quarterly result was a clear beat: EPS of $9.76 compared with the $6.89 estimate, a difference of $2.87, or about 42%. That is a positive indicator for the quarter, not proof that the earnings pace will persist. The next listed report is expected February 3, 2027, with an EPS estimate of $9.69.

Other supplied data require caution. A supplemental Yahoo Finance snapshot lists revenue growth of 0.50% and earnings growth of negative 42.40%, but it also gives trailing EPS of $44.25 rather than the provided $46.28. It reports a different current ratio and market price targets as well. The periods and calculation methods are not reconciled in the source material, so these figures should not be combined as though they describe one consistent reporting date. For insurers, premium growth alone is also insufficient: loss costs, catastrophe claims, policy retention and investment income affect the quality of earnings.

Balance Sheet Highlights

The provided company metrics include a current ratio of 1.40, but an external snapshot lists 0.42 and a quick ratio of 0.31. Traditional liquidity ratios are less informative for insurers than for many industrial companies because policy liabilities, investment portfolios and regulatory capital shape the balance sheet. The external snapshot reports $6.33 billion of cash, $7.49 billion of debt and debt-to-equity of 23.21%; these are useful reference points, but should be checked against Allstate’s filings before drawing conclusions about financial flexibility.

Reported ROE is high at 36.32%, with the external snapshot showing 38.93%. Strong returns can reflect underwriting performance, investment results and financial leverage, but a single high ROE figure doesn’t establish that returns are durable through a severe claims cycle.

Valuation Analysis

Current Valuation Metrics

Forward P/E~9.4Using supplemental forward EPS of $28.48
PEG Ratio1.96Supplemental vendor figure
EV/EBITDA4.44Supplemental vendor figure
P/S Ratio~0.94Market cap divided by vendor revenue

The forward P/E estimate is calculated from the $267.64 share price and supplemental forward EPS of $28.48. The P/S estimate uses the $66.23 billion market capitalization and the supplemental revenue figure of approximately $70.23 billion. These calculations are indicative, not directly comparable with standardized peer data. No verified industry average or five-year valuation series was supplied, so a precise peer discount or historical percentile can’t be established here.

Historical Comparison

The supplemental data show an average closing price of $209.20 over two years and a 42.04% total return over that period. Those figures suggest ALL has appreciated meaningfully from its two-year average, but share price history alone isn’t a valuation comparison because earnings, catastrophe costs and interest rates change over time. The share price is also below its 52-week high of $281.11, after reaching a 52-week low of $191.13.

Fair Value Estimate

The supplied analyst mean target of $266.47 is 0.4% below the $267.64 price, effectively indicating a near-market consensus estimate. The supplemental Yahoo Finance mean target of $277.55 is higher, illustrating disagreement between feeds rather than a dependable single fair-value answer. A low trailing multiple may reflect strong recent earnings, but if earnings normalize lower, the apparent cheapness could narrow. A dependable discounted cash-flow estimate would require assumptions for underwriting margins, catastrophe losses, capital needs and investment returns that aren’t available in the supplied data.

Competitive Landscape

Market Position

Market Share: Not specified in the supplied data | Ranking: Major U.S. personal-lines insurer; exact current ranking not verified

Allstate competes in a large, price-sensitive market where customers can compare coverage and switch providers, while insurers differentiate through claims handling, pricing accuracy, service and distribution. A current market-share percentage would require a consistent industry dataset, which wasn’t supplied; assigning a precise figure here would imply more certainty than the evidence supports.

Key Competitors

$PGRProgressive, a major auto insurer with direct and agency distribution.
The Travelers Companies (TRV)Travelers, a broad property and casualty insurer with personal and commercial lines.
$CBChubb, a global insurer with significant commercial and specialty operations.

Competitive Advantages

  • Brand and reach: Allstate’s national name recognition and broad agent and direct presence give it multiple routes to reach customers.
  • Data and pricing: Telematics and claims information can help refine pricing and risk selection, subject to regulatory and customer considerations.
  • Scale and service network: A large policy base can support investment in technology, claims capabilities and marketing, although scale doesn’t guarantee lower claims costs or better margins.

Earnings Track Record

Last 4 Quarters: 1 reported beat in supplied data / 0 confirmed misses, 3 quarters not provided

Recent Earnings History

Q3 2026$9.76 vs $6.89 estBEAT
Q2 2026Actual and estimate not providedN/A
Q1 2026Actual and estimate not providedN/A
Q4 2025Actual and estimate not providedN/A

Guidance Trend

No formal full-year guidance revisions were included. The next quarterly EPS consensus estimate is $9.69 for the report expected February 3, 2027. That estimate is a market expectation, not company guidance. The key question is whether underwriting profitability can support earnings near that level after claims costs, weather losses and pricing actions are accounted for.

Analyst Sentiment

Consensus Rating: Buy, according to the supplied analyst survey

Strong Buy: 2 Buy: 9 Hold: 11 Sell: 2 Strong Sell: 2

The 26-analyst breakdown is mixed: 11 analysts are in the Buy or Strong Buy categories, 11 are Hold, and four are Sell or Strong Sell. A separate vendor snapshot counts 22 opinions and labels its recommendation key Hold, so consensus labels vary with the provider and sample. The overall balance, rather than a single label, is more informative for this report.

Price Targets

  • Low: $221
  • Mean: $266.47 (-0.4% vs. $267.64)
  • High: $319

The supplemental vendor dataset gives a different range, $191 to $370, and mean of $277.55. That dispersion underscores forecast uncertainty. Targets are analyst estimates, not guaranteed outcomes or company forecasts.

Recent Analyst Actions

On November 10, UBS maintained Neutral and raised its target from $275 to $283. Morgan Stanley maintained Equal-Weight and raised its target from $240 to $260. Keefe, Bruyette & Woods maintained Underperform and raised its target from $232 to $241. Piper Sandler maintained Overweight while lowering its target from $300 to $294 on November 9. The varied ratings and target changes point to differing views on valuation and earnings durability.

Recent News & Catalysts

Key Developments

  • Quarterly dividend: Allstate announced a $1.08 per-share quarterly dividend, payable January 4, 2027. At the supplied share price, the stated yield is 1.58%; future payments remain subject to board approval.
  • CEO discussion: Tom Wilson addressed affordability, autonomous vehicles, AI and the economy in a November 10 CNBC interview. These topics could affect claims frequency, customer costs and operating efficiency over time.
  • Seasonal driving data: Allstate’s Thanksgiving report cited a nearly 200% jump in high-speed driving on Thanksgiving morning based on Drivewise data. The report is a safety-oriented company release, not evidence of a direct near-term earnings change.
  • Institutional ownership: Allspring Global Investments Holdings reportedly increased its position by 18.6% in the third quarter. One manager’s disclosed position change is a data point, not a broad measure of institutional sentiment.
  • Value commentary: A November 13 Zacks article described ALL as a value stock. That is third-party commentary and should be weighed against the earnings volatility and conflicting target estimates discussed above.

Upcoming Catalysts

Next Earnings: February 3, 2027, expected | Key Events: Q4 and full-year results, catastrophe losses, renewal pricing, claims trends, dividend record and payment dates

For the week beginning Monday, November 16, the supplied materials identify no specific company earnings event. Relevant broader watchpoints include new weather or catastrophe developments and any company updates affecting pricing or affordability. The market was closed on Saturday, November 14, so the $267.64 reference remains Friday’s close.

Technical Outlook

Current Price: $267.64 as of Friday, November 13 vs 52-Week High: $281.11 (-4.8% from high)

Trend Analysis

ALL ended Friday up $0.95, or 0.36%, from the prior close of $266.69, within a session range of $266.08 to $269.69. The price is about 84.9% of the way from its 52-week low to high, placing it in the upper portion of that range. The supplied information doesn’t include moving averages, trading volume for Friday, or momentum indicators, so this is a range-based observation rather than a full technical signal.

Key Levels

  • Resistance: Approximately $269.69, the November 13 session high, then $281.11, the 52-week high
  • Support: Approximately $266.08, the November 13 session low, then the $260 area as a round-number reference; the broader 52-week low is $191.13

These levels are reference points drawn from the supplied price range, not verified support or resistance zones. A move through a single level wouldn’t by itself establish a durable trend.

Bull vs Bear Case

Bull Case

  • Earnings beat: Q3 EPS exceeded consensus by about 42%, giving evidence of stronger-than-expected recent profitability.
  • Stated valuation: The supplied trailing P/E of 5.98 is low in absolute terms, although it depends on earnings that may fluctuate.
  • Capital return and operations: The $1.08 quarterly dividend and potential benefits from pricing, data and technology provide factors analysts may monitor positively.

Bull Scenario Reference: $319, the supplied analyst high target, about 19.2% above Friday’s close. This is an analyst estimate, not a forecast from this report.

Bear Case

  • Earnings normalization: Recent EPS could be unusually strong; the supplemental snapshot’s negative earnings-growth figure raises a question about sustainability.
  • Insurance loss exposure: Severe weather, rising repair costs, litigation or adverse claims development could pressure underwriting results.
  • Limited consensus gap: The supplied target mean is essentially at the share price, while analyst opinions include four Sell or Strong Sell ratings.

Bear Scenario Reference: $221, the supplied analyst low target, about 17.4% below Friday’s close. This is an analyst estimate, not a forecast from this report.

Risks to Consider

  • Valuation Risk: A low trailing P/E can be misleading if the earnings base is temporarily elevated. The differing EPS and target figures in supplied data also make direct comparisons less reliable.
  • Competitive Risk: Auto and homeowners customers can compare prices and switch carriers. Aggressive pricing by competitors could affect retention, growth or underwriting margins.
  • Macro Risk: Inflation in vehicle repair, replacement parts, medical costs and home construction can increase claims severity. Interest rates and financial-market changes can also affect investment income and portfolio values.
  • Execution Risk: Rate changes may take time to earn through and can influence customer affordability. Technology and AI investments must deliver operational benefits while meeting privacy, regulatory and model-risk requirements.
  • Catastrophe and reserve risk: Weather losses can be volatile, while estimates for prior-period claims may change. These risks can cause quarterly results to differ substantially from consensus.
  • Data risk: The supplied current ratio, ROE, EPS and target data conflict with a supplemental vendor snapshot. Investors reviewing the company should verify reporting periods and definitions in primary filings.

Bottom Line

Investment Verdict: NEUTRAL

Allstate combines a strong reported earnings surprise, high stated ROE and a relatively low trailing P/E with meaningful insurance-cycle risk and inconsistent supplemental financial figures. With the supplied analyst mean target almost equal to Friday’s price and ratings split between Buy, Hold and Sell categories, the evidence supports monitoring earnings quality and claims trends rather than relying on the headline multiple alone.

Action Items for Investors

  • Long-term investors: Track underwriting margins, policy growth and retention, catastrophe losses, and the company’s explanation of earnings changes in its next filings. Compare the dividend with cash generation and capital requirements over time.
  • Short-term traders: Treat the Friday range and 52-week high as historical reference levels, not trading signals. Earnings on February 3, 2027, and any material catastrophe news may affect volatility.
  • Risk management: Check primary company filings for reconciled EPS, liquidity and debt measures, and account for the possibility of sharp claims-driven earnings changes. This report is informational, not personalized investment advice.

What to Watch This Week

  • Any company announcements or material catastrophe developments after the market reopens Monday, November 16.
  • Price behavior relative to Friday’s $266.08 to $269.69 session range, with no assumption that those levels will hold.
  • Updates to analyst estimates and the distinction between reported earnings, underlying underwriting performance and one-time effects.

Share this report

Share this article

Spread the word on social media

Think ALL will outperform? Prove it.

Free practice contests — earn Alpha Coins
Enter a Contest

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.

Spotted something wrong? Report an error.